Literature DB >> 378260

Fractionation and structural elucidation of the active components of aurintricarboxylic acid, a potent inhibitor of protein nucleic acid interactions.

R G González, B J Blackburn, T Schleich.   

Abstract

Commercially available, as well as synthetically prepared, samples of aurintricarboxylic acid (a widely employed potent inhibitor of protein nucleic acid interactions) consist mostly of a heterogeneous collection of polymers, as shown by fractionation schemes utilizing both dialysis and ultrafiltration, and by molecular weight measurements. 13C-NMR studies suggest that the polymeric material is of the phenol-formaldehyde type; inhibitory assays that depend on the formation of a protein-nucleic acid complex revealed that potency varied directly with the molecular weight of the polymer. Fractions of molecular weight 400 were essentially inactive.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378260     DOI: 10.1016/0005-2787(79)90116-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Effects of herpes simplex virus on mRNA stability.

Authors:  T Strom; N Frenkel
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

2.  Characterization of Aurintricarboxylic Acid (ATA) Interactions with Plasma Transporter Protein and SARS-CoV-2 Viral Targets: Correlation of Functional Activity and Binding Energetics.

Authors:  Conceição A Minetti; David P Remeta; Keiji Hashimoto; Radha Bonala; Rajesh Chennamshetti; Xingyu Yin; Miguel Garcia-Diaz; Arthur P Grollman; Francis Johnson; Viktoriya S Sidorenko
Journal:  Life (Basel)       Date:  2022-06-10

3.  Aurintricarboxylic acid is a potent inhibitor of phosphofructokinase.

Authors:  S A McCune; L G Foe; R G Kemp; R R Jurin
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

4.  Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP.

Authors:  William R Shadrick; Sourav Mukherjee; Alicia M Hanson; Noreena L Sweeney; David N Frick
Journal:  Biochemistry       Date:  2013-08-26       Impact factor: 3.162

5.  Characterization and use of the potent ribonuclease inhibitor aurintricarboxylic acid for the isolation of RNA from animal tissues.

Authors:  A F Skidmore; T J Beebee
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.

Authors:  Jared S Morse; Tyler Lalonde; Shiqing Xu; Wenshe Ray Liu
Journal:  Chembiochem       Date:  2020-02-25       Impact factor: 3.164

Review 7.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

8.  Novel Bacterial Diversity and Fragmented eDNA Identified in Hyperbiofilm-Forming Pseudomonas aeruginosa Rugose Small Colony Variant.

Authors:  Binbin Deng; Subhadip Ghatak; Subendu Sarkar; Kanhaiya Singh; Piya Das Ghatak; Shomita S Mathew-Steiner; Sashwati Roy; Savita Khanna; Daniel J Wozniak; David W McComb; Chandan K Sen
Journal:  iScience       Date:  2020-01-09

9.  Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor.

Authors:  T L Deckwerth; E M Johnson
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

10.  In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.

Authors:  Pavel Klein; Oscar Cirioni; Andrea Giacometti; Giorgio Scalise
Journal:  J Antimicrob Chemother       Date:  2008-07-23       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.